Survivin signalling in the heart

Journal of Molecular and Cellular Cardiology

Volumn 50, Issue 1, 2011, Pages 6-8

  Levkau, Bodo ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 43; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; POTASSIUM; PROTEIN BAX; PROTEIN KINASE B; S6 KINASE; SURVIVIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; X LINKED INHIBITOR OF APOPTOSIS;

ACUTE CORONARY SYNDROME; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; CELL DIVISION; EDITORIAL; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TISSUE REGENERATION; VASODILATATION;

ANIMALS; APOPTOSIS; INSULIN; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; PHOSPHATIDYLINOSITOL 3-KINASE; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 78650841816     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.10.013     Document Type: Editorial

References (50)

1. Gyrd-Hansen M., Meier P. IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer. Nat Rev Cancer 2010, 10:561-574.
2. Altieri D.C. Survivin and IAP proteins in cell-death mechanisms. Biochem J 2010, 430:199-205.
3. Vaux D.L., Silke J. IAPs, RINGs and ubiquitylation. Nat Rev Mol Cell Biol 2005, 6:287-297.
4. Lens S.M., Vader G., Medema R.H. The case for Survivin as mitotic regulator. Curr Opin Cell Biol 2006, 18:616-622.
5. Jeyaprakash A.A., Klein U.R., Lindner D., Ebert J., Nigg E.A., Conti E. Structure of a Survivin-Borealin-INCENP core complex reveals how chromosomal passengers travel together. Cell 2007, 131:271-285.
6. Uren A.G., Wong L., Pakusch M., Fowler K.J., Burrows F.J., Vaux D.L., et al. Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype. Curr Biol 2000, 10:1319-1328.
7. Conway E.M., Pollefeyt S., Steiner-Mosonyi M., Luo W., Devriese A., Lupu F., et al. Deficiency of survivin in transgenic mice exacerbates Fas-induced apoptosis via mitochondrial pathways. Gastroenterology 2002, 123:619-631.
8. Altznauer F., Martinelli S., Yousefi S., Thurig C., Schmid I., Conway E.M., et al. Inflammation-associated cell cycle-independent block of apoptosis by survivin in terminally differentiated neutrophils. J Exp Med 2004, 199:1343-1354.
9. Xing Z., Conway E.M., Kang C., Winoto A. Essential role of survivin, an inhibitor of apoptosis protein, in T cell development, maturation, and homeostasis. J Exp Med 2004, 199:69-80.
10. Leung C.G., Xu Y., Mularski B., Liu H., Gurbuxani S., Crispino J.D. Requirements for survivin in terminal differentiation of erythroid cells and maintenance of hematopoietic stem and progenitor cells. J Exp Med 2007, 204:1603-1611.
11. Jiang Y., de Bruin A., Caldas H., Fangusaro J., Hayes J., Conway E.M., Robinson M.L., Altura R.A. Essential role for survivin in early brain development. J Neurosci 2005, 25:6962-6970.
12. Conway E.M., Zwerts F., Van Eygen V., DeVriese A., Nagai N., Luo W., et al. Survivin-dependent angiogenesis in ischemic brain: molecular mechanisms of hypoxia-induced up-regulation. Am J Pathol 2003, 163:935-946.
13. Zwerts F., Lupu F., De Vriese A., Pollefeyt S., Moons L., Altura R.A., et al. Lack of endothelial cell survivin causes embryonic defects in angiogenesis, cardiogenesis, and neural tube closure. Blood 2007, 109:4742-4752.
14. Okada H., Mak T.W. Pathways of apoptotic and non-apoptotic death in tumour cells. Nat Rev Cancer 2004, 4:592-603.
15. Gurbuxani S., Xu Y., Keerthivasan G., Wickrema A., Crispino J.D. Differential requirements for survivin in hematopoietic cell development. Proc Natl Acad Sci USA 2005, 102:11480-11485.
16. Santini D., Abbate A., Scarpa S., Vasaturo F., Biondi-Zoccai G.G., Bussani R., et al. Surviving acute myocardial infarction: survivin expression in viable cardiomyocytes after infarction. J Clin Pathol 2004, 57:1321-1324.
17. Levkau B., Schafers M., Wohlschlaeger J., von Wnuck Lipinski K., Keul P., Hermann S., et al. Survivin determines cardiac function by controlling total cardiomyocyte number. Circulation 2008, 117:1583-1593.
18. Abbate A., Scarpa S., Santini D., Palleiro J., Vasaturo F., Miller J., et al. Myocardial expression of survivin, an apoptosis inhibitor, in aging and heart failure. An experimental study in the spontaneously hypertensive rat. Int J Cardiol 2006, 111:371-376.
19. Si R., Tao L., Zhang H.F., Yu QJ., Zhang R., Lv AL., et al. Survivin: a novel player in insulin cardioprotection against myocardial ischemia/reperfusion injury. J Mol Cell Cardiol 2010, 50:16-24.
20. Heusch G. No risk, no .... cardioprotection? A critical perspective. Cardiovasc Res 2009, 84:173-175.
21. Jonassen A.K., Sack M.N., Mjos O.D., Yellon D.M. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res 2001, 89:1191-1198.
22. Hausenloy D.J., Yellon D.M. Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail Rev 2007, 12:217-234.
23. Gao F., Gao E., Yue T.L., Ohlstein E.H., Lopez B.L., Christopher T.A., et al. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 2002, 105:1497-1502.
24. Hausenloy D.J., Yellon D.M. Cardioprotective growth factors. Cardiovasc Res 2009, 83:179-194.
25. Ji L., Fu F., Zhang L., Liu W., Cai X., Zheng Q., et al. Insulin attenuates myocardial ischemia/reperfusion injury via reducing oxidative/nitrative stress. Am J Physiol Endocrinol Metab 2010, 298:E871-E880.
26. Heusch G., Boengler K., Schulz R. Inhibition of mitochondrial permeability transition pore opening: the Holy Grail of cardioprotection. Basic Res Cardiol 2010, 105:151-154.
27. Kloner R.A., Nesto R.W. Glucose-insulin-potassium for acute myocardial infarction: continuing controversy over cardioprotection. Circulation 2008, 117:2523-2533.
28. Yaoita H., Ogawa K., Maehara K., Maruyama Y. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation 1998, 97:276-281.
29. Mocanu M.M., Baxter G.F., Yellon D.M. Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury. Br J Pharmacol 2000, 130:197-200.
30. Dohi T., Okada K., Xia F., Wilford C.E., Samuel T., Welsh K., et al. An IAP-IAP complex inhibits apoptosis. J Biol Chem 2004, 279:34087-34090.
31. Dohi T., Xia F., Altieri D.C. Compartmentalized phosphorylation of IAP by protein kinase A regulates cytoprotection. Mol Cell 2007, 27:17-28.
32. Song Z., Yao X., Wu M. Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis. J Biol Chem 2003, 278:23130-23140.
33. Ceballos-Cancino G., Espinosa M., Maldonado V., Melendez-Zajgla J. Regulation of mitochondrial Smac/DIABLO-selective release by survivin. Oncogene 2007, 26:7569-7575.
34. Fortugno P., Beltrami E., Plescia J., Fontana J., Pradhan D., Marchisio P.C., et al. Regulation of survivin function by Hsp90. Proc Natl Acad Sci USA 2003, 100:13791-13796.
35. Ghosh J.C., Dohi T., Kang B.H., Altieri D.C. Hsp60 regulation of tumor cell apoptosis. J Biol Chem 2008, 283:5188-5194.
36. Budas G.R., Churchill E.N., Disatnik M.H., Sun L., Mochly-Rosen D. Mitochondrial import of PKCepsilon is mediated by HSP90: a role in cardioprotection from ischaemia and reperfusion injury. Cardiovasc Res 2010, 88:83-92.
37. Rodriguez-Sinovas A., Boengler K., Cabestrero A., Gres P., Morente M., Ruiz-Meana M., et al. Translocation of connexin 43 to the inner mitochondrial membrane of cardiomyocytes through the heat shock protein 90-dependent TOM pathway and its importance for cardioprotection. Circ Res 2006, 99:93-101.
38. Lin K.M., Lin B., Lian I.Y., Mestril R., Scheffler I.E., Dillmann W.H. Combined and individual mitochondrial HSP60 and HSP10 expression in cardiac myocytes protects mitochondrial function and prevents apoptotic cell deaths induced by simulated ischemia-reoxygenation. Circulation 2001, 103:1787-1792.
39. Hollander J.M., Lin K.M., Scott B.T., Dillmann W.H. Overexpression of PHGPx and HSP60/10 protects against ischemia/reoxygenation injury. Free Radic Biol Med 2003, 35:742-751.
40. Guha M., Altieri D.C. Survivin as a global target of intrinsic tumor suppression networks. Cell Cycle 2009, 8:2708-2710.
41. Guha M., Xia F., Raskett C.M., Altieri D.C. Caspase 2-mediated tumor suppression involves survivin gene silencing. Oncogene 2010, 29:1280-1292.
42. Misra A., Haudek S.B., Knuefermann P., Vallejo J.G., Chen Z.J., Michael L.H., et al. Nuclear factor-kappaB protects the adult cardiac myocyte against ischemia-induced apoptosis in a murine model of acute myocardial infarction. Circulation 2003, 108:3075-3078.
43. Vaira V., Lee C.W., Goel H.L., Bosari S., Languino L.R., Altieri D.C. Regulation of survivin expression by IGF-1/mTOR signaling. Oncogene 2007, 26:2678-2684.
44. Wohlschlaeger J., Levkau B., Brockhoff B., Schmitz K.J., von Winterfeld M., Takeda A., et al. Hemodynamic support by left ventricular assist devices reduces cardiomyocyte DNA content in the failing human heart. Circulation 2010, 121:989-996.
45. Adler C.P., Friedburg H. Myocardial DNA content, ploidy level and cell number in geriatric hearts: post-mortem examinations of human myocardium in old age. J Mol Cell Cardiol 1986, 18:39-53.
46. Bergmann O., Bhardwaj R.D., Bernard S., Zdunek S., Barnabe-Heider F., Walsh S., Zupicich J., Alkass K., Buchholz B.A., Druid H., Jovinge S., Frisen J. Evidence for cardiomyocyte renewal in humans. Science 2009, 324:98-102.
47. Soonpaa M.H., Field L.J. Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ Res 1998, 83:15-26.
48. Bersell K., Arab S., Haring B., Kuhn B. Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell 2009, 138:257-270.
49. Beltrami A.P., Urbanek K., Kajstura J., Yan S.M., Finato N., Bussani R., Nadal-Ginard B., Silvestri F., Leri A., Beltrami C.A., Anversa P. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001, 344:1750-1757.
50. Murry C.E., Kuhn B. Taking a load off: nuclear remodeling after mechanically supporting the failing human heart. Circulation 2010, 121:957-959.